New research reveals semaglutide, the active ingredient in Wegovy, shows promise in treating metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease affecting millions. The study indicates significant improvements in liver health among participants, leading to hopes for FDA approval.
A recent study reveals that CT scans may be responsible for approximately 5% of all cancer diagnoses in the U.S., ranking alongside major cancer contributors like smoking and obesity. Experts urge caution in their use and the need for standardized radiation doses to mitigate risks.
Pfizer Inc. has decided to stop the development of its obesity pill, danuglipron, after safety concerns emerged from a clinical trial. This move comes as competition heats up with Novo Nordisk and Eli Lilly's successful weight-loss treatments.
A new clinical trial reveals that fasting every other day can lead to greater weight loss compared to traditional calorie cutting. Discover how this method may help you shed pounds more effectively!
A new study reveals that the 4:3 intermittent fasting method could lead to more significant weight loss than traditional daily calorie restriction. Discover how this approach may be the key to effective weight management.
Discover how Yerba mate, a traditional South American herbal tea, is gaining popularity for its potential weight loss benefits, possibly outperforming expensive weight-loss drugs like Ozempic. Learn about its health perks and celebrity endorsements!
Eli Lilly is set to unveil results from trials of orforglipron, its groundbreaking once-daily obesity pill, potentially revolutionizing weight loss treatment by offering a needle-free alternative. Analysts predict it could capture a significant share of the $150 billion GLP-1 market.
Colorectal cancer cases are surging among individuals aged 20 to 49, with alarming predictions for the future. Discover the lifestyle changes experts recommend to reduce your risk and the importance of early screening.
After decades of lobbying, the US government is finally warning consumers about the dangers of ultra-processed foods. With new nutrition labels proposed, experts weigh in on their potential effectiveness and what more needs to be done to improve public health.
Eli Lilly introduces discounted higher doses of the weight loss drug Zepbound in a move to make the treatment more accessible to uninsured patients and address the growing demand for obesity treatments.
